These preliminary results indicate that GLP-1RAs have a potentially beneficial effect on bone metabolism in postmenopausal patients
Consider factors such as experience, credentials, patient success rates, and the personalized care approach of each clinic.
Lu M, Kuroki M, Amano S, et al
Common culprits: liquid calories, low/paused dosing, lower daily movement, insulin resistance/meds, and losing muscle
Dose Escalation Schedule Based on the Phase 2 trial protocol, the escalation schedule for the 12mg maintenance cohort: How Retatrutide Dosing Compares to Other GLP-1 Peptides For a detailed head-to-head analysis, see our Semaglutide vs Retatrutide vs Tirzepatide Comparison
Patients should specifically inform their doctor about diabetes medications (insulin, sulfonylureas, meglitinides), thyroid medications, anticoagulants, oral contraceptives, and any medications requiring precise timing or absorption